Enact Holdings, Inc.
US ˙ NasdaqGS ˙ US29249E1091

Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Christopher J Coughlin. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Christopher J Coughlin har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:CNC / Centene Corporation Director 11.436
US:KRTX / Karuna Therapeutics, Inc. Director 0
US:PBH / Prestige Consumer Healthcare Inc. Director 13.218
US:US00C4W1JQ50 / Alexion Pharmaceuticals, Inc. Director 0
US:ACT / Enact Holdings, Inc. Director 0
NO:US23329PAB67 / DNB Bank ASA Director 38.317
US:HOLX / Hologic, Inc. Director 6.816
US:COV / Director 0
Director 0
US:DPRX / Dipexium Pharmaceuticals, Inc. Director 109.309
US:TYC / Tyco International plc EVP and CFO 184.700
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Christopher J Coughlin. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderkøb ACT / Enact Holdings, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i ACT / Enact Holdings, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2018-09-06 AGN COUGHLIN CHRISTOPHER J 1.300 190,5500 1.300 190,5500 247.715 27
2018-09-06 AGN COUGHLIN CHRISTOPHER J 705 190,5600 705 190,5600 134.345
2018-09-06 AGN COUGHLIN CHRISTOPHER J 27 190,5700 27 190,5700 5.145
2018-09-06 AGN COUGHLIN CHRISTOPHER J 100 190,5800 100 190,5800 19.058
2018-09-06 AGN COUGHLIN CHRISTOPHER J 356 190,5900 356 190,5900 67.850
2018-09-06 AGN COUGHLIN CHRISTOPHER J 400 190,6000 400 190,6000 76.240
2018-09-06 AGN COUGHLIN CHRISTOPHER J 200 190,6100 200 190,6100 38.122
2018-09-06 AGN COUGHLIN CHRISTOPHER J 68 190,6200 68 190,6200 12.962
2018-09-06 AGN COUGHLIN CHRISTOPHER J 100 190,6500 100 190,6500 19.065
2018-09-06 AGN COUGHLIN CHRISTOPHER J 816 190,6600 816 190,6600 155.579
2018-09-06 AGN COUGHLIN CHRISTOPHER J 222 190,6700 222 190,6700 42.329
2018-09-06 AGN COUGHLIN CHRISTOPHER J 4.889 190,6800 4.889 190,6800 932.235
2018-09-06 AGN COUGHLIN CHRISTOPHER J 517 190,6400 517 190,6400 98.561
2018-09-06 AGN COUGHLIN CHRISTOPHER J 300 190,6300 300 190,6300 57.189
2017-12-05 AGN COUGHLIN CHRISTOPHER J 10.000 163,3000 10.000 163,3000 1.633.000

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

ACT / Enact Holdings, Inc. Insider Trades
Insidersalg ACT / Enact Holdings, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i ACT / Enact Holdings, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

ACT / Enact Holdings, Inc. Insider Trades
Insiderkøb PBH / Prestige Consumer Healthcare Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i ACT / Enact Holdings, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

PBH / Prestige Consumer Healthcare Inc. Insider Trades
Insidersalg PBH / Prestige Consumer Healthcare Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i ACT / Enact Holdings, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

PBH / Prestige Consumer Healthcare Inc. Insider Trades
Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Christopher J Coughlin som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2025-07-02 2025-06-30 4 CNC CENTENE CORP
Common Stock
A - Award 556 11.436 5,11
2025-05-14 2025-05-13 4 CNC CENTENE CORP
Common Stock
A - Award 3.579 10.880 49,02
2025-04-02 2025-03-31 4 CNC CENTENE CORP
Common Stock
A - Award 500 7.301 7,35
2025-01-03 2024-12-31 4 CNC CENTENE CORP
Common Stock
A - Award 497 6.801 7,88
2024-12-17 2024-12-16 4 CNC CENTENE CORP
Common Stock
P - Purchase 10.000 36.358 37,94 59,44 594.400 2.161.115
2024-10-02 2024-09-30 4 CNC CENTENE CORP
Common Stock
A - Award 402 26.358 1,55
2024-07-02 2024-06-30 4 CNC CENTENE CORP
Common Stock
A - Award 452 25.956 1,77
2024-05-24 3/A CNC CENTENE CORP
Common Stock
878
2024-05-24 2024-05-14 4 CNC CENTENE CORP
Common Stock
S - Sale -878 0 -100,00 76,74 -67.382
2024-05-16 2024-05-14 4 CNC CENTENE CORP
Common Stock
A - Award 2.916 25.504 12,91
2024-04-02 2024-03-31 4 CNC CENTENE CORP
Common Stock
A - Award 389 22.588 1,75
2024-03-18 2024-03-18 4 KRTX Karuna Therapeutics, Inc.
Common Stock
D - Sale to Issuer -990 0 -100,00 330,00 -326.700
2024-01-03 2023-12-31 4 CNC CENTENE CORP
Common Stock
A - Award 502 22.199 2,32
2023-10-03 2023-09-30 4 CNC CENTENE CORP
Common Stock
A - Award 545 21.697 2,58
2023-07-05 2023-06-30 4 CNC CENTENE CORP
Common Stock
A - Award 544 21.152 2,64
2023-06-22 2023-06-20 4 KRTX Karuna Therapeutics, Inc.
Common Stock
A - Award 990 990
2023-05-12 2023-05-10 4 CNC CENTENE CORP
Common Stock
A - Award 2.947 20.608 16,69
2023-04-04 2023-03-31 4 CNC CENTENE CORP
Common Stock
A - Award 511 17.661 2,98
2023-01-04 2022-12-31 4 CNC CENTENE CORP
Common Stock
A - Award 444 17.151 2,66
2022-10-04 2022-09-30 4 CNC CENTENE CORP
Common Stock
A - Award 406 16.707 2,49
2022-08-03 2022-08-02 4 PBH Prestige Consumer Healthcare Inc.
Common Stock, par value $0.01 per share
A - Award 2.495 13.218 23,27
2022-07-05 2022-06-30 4 CNC CENTENE CORP
Common Stock
A - Award 436 16.301 2,75
2022-05-03 2022-04-29 4 CNC CENTENE CORP
Common Stock
P - Purchase 12.000 15.865 310,48 81,37 976.440 1.290.932
2022-04-28 2022-04-26 4 CNC CENTENE CORP
Common Stock
A - Award 2.323 3.865 150,65
2022-04-04 2022-03-31 4 CNC CENTENE CORP
Common Stock
A - Award 442 1.542 40,18 82,02 36.250 126.472
2022-02-09 2022-02-07 4 CNC CENTENE CORP
Common Stock Option (right to buy)
A - Award 10.000 10.000
2022-02-09 2022-02-07 4 CNC CENTENE CORP
Common Stock
A - Award 1.100 1.100
2022-01-14 3 CNC CENTENE CORP
No Securities Beneficially Owned
0
2021-08-05 2021-08-03 4 PBH Prestige Consumer Healthcare Inc.
Common Stock, par value $0.01 per share
A - Award 2.808 10.723 35,48
2021-07-23 2021-07-21 4 ALXN ALEXION PHARMACEUTICALS, INC.
Option to Purchase Common Stock
D - Sale to Issuer -2.343 0 -100,00 155,01 -363.188
2021-07-23 2021-07-21 4 ALXN ALEXION PHARMACEUTICALS, INC.
Option to Purchase Common Stock
D - Sale to Issuer -2.706 0 -100,00 167,97 -454.527
2021-07-23 2021-07-21 4 ALXN ALEXION PHARMACEUTICALS, INC.
Option to Purchase Common Stock
D - Sale to Issuer -2.294 0 -100,00 138,86 -318.545
2021-07-23 2021-07-21 4 ALXN ALEXION PHARMACEUTICALS, INC.
Common Stock, par value $.0001 per share
D - Sale to Issuer -42.347 0 -100,00
2021-06-23 2021-06-16 4 KRTX Karuna Therapeutics, Inc.
Option (right to buy)
A - Award 8.500 8.500
2021-05-24 2021-05-20 4 ALXN ALEXION PHARMACEUTICALS, INC.
Common Stock, par value $.0001 per share
A - Award 729 42.347 1,75
2021-05-24 2021-05-20 4 ALXN ALEXION PHARMACEUTICALS, INC.
Common Stock, par value $.0001 per share
A - Award 1.962 41.618 4,95
2020-08-06 2020-08-04 4 PBH Prestige Consumer Healthcare Inc.
Common Stock, par value $0.01 per share
A - Award 3.732 7.915 89,22
2020-05-18 2020-05-14 4 ALXN ALEXION PHARMACEUTICALS, INC.
Common Stock, par value $.0001 per share
A - Award 2.774 39.656 7,52
2020-05-18 2020-05-14 4 ALXN ALEXION PHARMACEUTICALS, INC.
Common Stock, par value $.0001 per share
A - Award 3.468 36.882 10,38
2020-05-11 2020-05-08 4 AGN Allergan plc
Stock Options
D - Sale to Issuer -9.446 0 -100,00
2020-05-11 2020-05-08 4 AGN Allergan plc
Stock Options
D - Sale to Issuer -3.691 0 -100,00
2020-05-11 2020-05-08 4 AGN Allergan plc
Stock Options
D - Sale to Issuer -2.790 0 -100,00
2020-05-11 2020-05-08 4 AGN Allergan plc
Ordinary Shares, par value $0.0001
D - Sale to Issuer -16.532 0 -100,00
2020-05-11 2020-05-08 4 AGN Allergan plc
Ordinary Shares, par value $0.0001
D - Sale to Issuer -9.538 16.542 -36,57
2020-05-11 2020-05-08 4 AGN Allergan plc
Ordinary Shares, par value $0.0001
D - Sale to Issuer -471 26.080 -1,77
2020-05-04 2020-05-01 4 AGN Allergan plc
Ordinary Shares, par value $0.0001
F - Taxes -991 16.542 -5,65 189,74 -188.032 3.138.679
2020-04-28 2020-04-24 4 KRTX Karuna Therapeutics, Inc.
Option (right to buy)
A - Award 25.000 25.000
2020-02-13 2019-06-18 5 AGN Allergan plc
Ordinary Shares, par value $0.0001
G - Gift -9.538 12.776 -42,74
2019-08-01 3 PBH Prestige Consumer Healthcare Inc.
Common Stock, par value $0.01 per share
0
2019-08-01 2019-07-30 4 PBH Prestige Consumer Healthcare Inc.
Common Stock, par value $0.01 per share
A - Award 4.183 4.183
2019-05-17 2019-05-15 4 ALXN ALEXION PHARMACEUTICALS, INC.
Common Stock, par value $.0001 per share
A - Award 2.181 33.414 6,98
2019-05-17 2019-05-15 4 ALXN ALEXION PHARMACEUTICALS, INC.
Common Stock, par value $.0001 per share
A - Award 2.726 31.233 9,56
2019-05-02 2019-05-02 4 AGN Allergan plc
Ordinary Shares, par value $0.0001
A - Award 2.064 17.080 13,75 145,33 299.961 2.482.236
2019-05-02 2019-04-30 4 AGN Allergan plc
Ordinary Shares, par value $0.0001
F - Taxes -953 15.016 -5,97 147,00 -140.091 2.207.352
2018-09-07 2018-09-06 4 AGN Allergan plc
Ordinary Shares, par value $0.0001
P - Purchase 300 16.431 1,86 190,63 57.189 3.132.242
2018-09-07 2018-09-06 4 AGN Allergan plc
Ordinary Shares, par value $0.0001
P - Purchase 517 16.131 3,31 190,64 98.561 3.075.214
2018-09-07 2018-09-06 4 AGN Allergan plc
Ordinary Shares, par value $0.0001
P - Purchase 4.889 15.614 45,59 190,68 932.235 2.977.278
2018-09-07 2018-09-06 4 AGN Allergan plc
Ordinary Shares, par value $0.0001
P - Purchase 222 10.725 2,11 190,67 42.329 2.044.936
2018-09-07 2018-09-06 4 AGN Allergan plc
Ordinary Shares, par value $0.0001
P - Purchase 816 10.503 8,42 190,66 155.579 2.002.502
2018-09-07 2018-09-06 4 AGN Allergan plc
Ordinary Shares, par value $0.0001
P - Purchase 100 9.687 1,04 190,65 19.065 1.846.827
2018-09-07 2018-09-06 4 AGN Allergan plc
Ordinary Shares, par value $0.0001
P - Purchase 68 9.587 0,71 190,62 12.962 1.827.474
2018-09-07 2018-09-06 4 AGN Allergan plc
Ordinary Shares, par value $0.0001
P - Purchase 200 9.519 2,15 190,61 38.122 1.814.417
2018-09-07 2018-09-06 4 AGN Allergan plc
Ordinary Shares, par value $0.0001
P - Purchase 400 9.319 4,48 190,60 76.240 1.776.201
2018-09-07 2018-09-06 4 AGN Allergan plc
Ordinary Shares, par value $0.0001
P - Purchase 356 8.919 4,16 190,59 67.850 1.699.872
2018-09-07 2018-09-06 4 AGN Allergan plc
Ordinary Shares, par value $0.0001
P - Purchase 100 8.563 1,18 190,58 19.058 1.631.937
2018-09-07 2018-09-06 4 AGN Allergan plc
Ordinary Shares, par value $0.0001
P - Purchase 27 8.463 0,32 190,57 5.145 1.612.794
2018-09-07 2018-09-06 4 AGN Allergan plc
Ordinary Shares, par value $0.0001
P - Purchase 705 8.436 9,12 190,56 134.345 1.607.564
2018-09-07 2018-09-06 4 AGN Allergan plc
Ordinary Shares, par value $0.0001
P - Purchase 1.300 7.731 20,21 190,55 247.715 1.473.142
2018-05-11 2018-05-09 4 ALXN ALEXION PHARMACEUTICALS INC
Common Stock, par value $.0001 per share
A - Award 2.174 28.507 8,26
2018-05-04 2018-05-02 4 AGN Allergan plc
Ordinary Shares, par value $0.0001
A - Award 1.985 6.431 44,65 151,07 299.874 971.531
2018-05-04 2018-02-28 4 AGN Allergan plc
Ordinary Shares, par value $0.0001
G - Gift -10.000 4.446 -69,22
2018-05-02 2018-04-30 4 ALXN ALEXION PHARMACEUTICALS INC
Common Stock, par value $.0001 per share
P - Purchase 10.000 26.333 61,23 120,79 1.207.900 3.180.763
2017-12-05 2017-12-05 4 AGN Allergan plc
Ordinary Shares, par value $0.0001
P - Purchase 10.000 14.446 224,92 163,30 1.633.000 2.359.032
2017-12-05 2017-12-05 4 ALXN ALEXION PHARMACEUTICALS INC
Common Stock, par value $.0001 per share
A - Award 10.000 16.333 157,90 112,75 1.127.500 1.841.546
2017-06-16 2017-06-15 4 ALXN ALEXION PHARMACEUTICALS INC
Common Stock, par value $.0001 per share
P - Purchase 2.000 6.333 46,16 117,10 234.200 741.594
2017-05-12 2017-05-10 4 ALXN ALEXION PHARMACEUTICALS INC
Common Stock, par value $.0001 per share
A - Award 2.030 4.333 88,15
2017-05-05 2017-05-04 4 AGN Allergan plc
Ordinary Shares, par value $0.0001
A - Award 1.223 4.446 37,95 245,25 299.941 1.090.382
2017-05-05 2017-05-03 4 AGN Allergan plc
Ordinary Shares, par value $0.0001
F - Taxes -668 3.223 -17,17 243,76 -162.832 785.638
2017-03-13 2017-03-10 4 DNB DUN & BRADSTREET CORP/NW
Phantom Stock Units - Deferred Compensation
A - Award 175 38.317 0,46 40,29 7.054 1.543.796
2017-03-13 2017-03-10 4 DNB DUN & BRADSTREET CORP/NW
Common Stock
A - Award 75 16.536 0,45 107,81 8.048 1.782.736
2017-03-09 2017-03-08 4 HOLX HOLOGIC INC
Non-qualified Stock Option (Right to Buy)
A - Award 6.816 6.816
2017-03-09 2017-03-08 4 HOLX HOLOGIC INC
Restricted Stock Unit Award (Right To Receive)
M - Exercise -2.427 0 -100,00
2017-03-09 2017-03-08 4 HOLX HOLOGIC INC
Common Stock
A - Award 2.206 7.633 40,65
2017-03-09 2017-03-08 4 HOLX HOLOGIC INC
Common Stock
M - Exercise 2.427 5.427 80,90
2017-02-02 2017-01-31 4 DNB DUN & BRADSTREET CORP/NW
Phantom Stock Units - Deferred Compensation
A - Award 728 38.142 1,95 45,73 33.301 1.744.235
2017-01-27 2017-01-26 4 DNB DUN & BRADSTREET CORP/NW
Non-Qualified Stock Option (right to buy)
M - Exercise -2.086 0 -100,00
2017-01-27 2017-01-26 4 DNB DUN & BRADSTREET CORP/NW
Common Stock
M - Exercise 2.086 18.547 12,67 88,04 183.651 1.632.901
2016-12-13 2016-12-09 4 DNB DUN & BRADSTREET CORP/NW
Phantom Stock Units - Deferred Compensation
A - Award 144 37.414 0,39 46,00 6.605 1.721.035
2016-12-13 2016-12-09 4 DNB DUN & BRADSTREET CORP/NW
Common Stock
A - Award 63 16.461 0,38 122,96 7.698 2.024.035
2016-09-13 2016-09-09 4 DNB DUN & BRADSTREET CORP/NW
Phantom Stock Units - Deferred Compensation
A - Award 133 37.270 0,36 49,52 6.580 1.845.622
2016-09-13 2016-09-09 4 DNB DUN & BRADSTREET CORP/NW
Common Stock
A - Award 57 16.399 0,35 134,56 7.670 2.206.603
2016-08-17 2016-08-15 4 AGN Allergan plc
Ordinary Shares, par value $0.0001
F - Taxes -100 3.891 -2,51 254,05 -25.405 988.509
2016-08-09 2016-08-08 4 AGN Allergan plc
Ordinary Shares, par value $0.0001
A - Award 201 3.991 5,30 248,31 49.910 991.005
2016-07-05 2016-06-30 4 DNB DUN & BRADSTREET CORP/NW
Phantom Stock Units - Deferred Compensation
A - Award 2.300 37.137 6,60 45,44 104.500 1.687.521
2016-06-14 2016-06-10 4 DNB DUN & BRADSTREET CORP/NW
Phanton Stock Units - Deferred Compensation
A - Award 131 34.838 0,38 46,88 6.159 1.633.188
2016-06-14 2016-06-10 4 DNB DUN & BRADSTREET CORP/NW
Common Stock
A - Award 61 16.342 0,37 126,04 7.641 2.059.620
2016-05-13 2016-05-11 4 ALXN ALEXION PHARMACEUTICALS INC
Option to Purchase Common Stock
A - Award 2.294 2.294 138,86 318.545 318.545
2016-05-13 2016-05-11 4 ALXN ALEXION PHARMACEUTICALS INC
Common Stock, par value $.0001 per share
A - Award 835 2.303 56,88
2016-05-09 2016-05-05 4 AGN Allergan plc
Ordinary Shares, par value $0.0001
A - Award 1.188 3.790 45,66 210,34 249.884 797.189
2016-05-06 2016-05-04 4 DNB DUN & BRADSTREET CORP/NW
Common Stock
A - Award 1.087 16.281 7,15
2016-03-15 2016-03-11 4 DNB DUN & BRADSTREET CORP/NW
Phantom Stock Units - Deferred Compensation
A - Award 164 34.706 0,48 37,41 6.147 1.298.360
2016-03-15 2016-03-11 4 DNB DUN & BRADSTREET CORP/NW
Common Stock
A - Award 72 15.194 0,47 98,98 7.082 1.503.828
2016-03-04 2016-03-02 4 HOLX HOLOGIC INC
Restricted Stock Unit Award (Right To Receive)
A - Award 2.427 2.427
2016-03-04 2016-03-02 4 HOLX HOLOGIC INC
Non-qualified Stock Option (Right to Buy)
A - Award 7.402 7.402
2016-03-04 3 HOLX HOLOGIC INC
Common Stock
6.000
2016-03-04 3 HOLX HOLOGIC INC
Common Stock
6.000
2016-02-02 2016-01-29 4 DNB DUN & BRADSTREET CORP/NW
Phantom Stock Units - Deferred Compensation
A - Award 2.837 34.542 8,95 36,84 104.500 1.272.524
2015-12-15 2015-12-11 4 DNB DUN & BRADSTREET CORP/NW
Phantom Stock Units - Deferred Compensation
A - Award 140 31.705 0,44 38,55 5.382 1.222.240
2015-12-15 2015-12-11 4 DNB DUN & BRADSTREET CORP/NW
Common Stock
A - Award 65 15.122 0,43 103,68 6.758 1.567.898
2015-11-10 2015-11-06 4 DNB DUN & BRADSTREET CORP/NW
Non-Qualified Stock Option - right to buy
M - Exercise -2.330 0 -100,00
2015-11-10 2015-11-06 4 DNB DUN & BRADSTREET CORP/NW
Common Stock
S - Sale -2.330 15.057 -13,40 112,50 -262.134 1.694.003
2015-11-10 2015-11-06 4 DNB DUN & BRADSTREET CORP/NW
Common Stock
M - Exercise 2.330 17.387 15,47 71,28 166.071 1.239.279
2015-09-15 2015-09-11 4 DNB DUN & BRADSTREET CORP/NW
Phantom Stock Units - Deferred Compensation
A - Award 136 31.566 0,43 39,26 5.351 1.239.270
2015-09-15 2015-09-11 4 DNB DUN & BRADSTREET CORP/NW
Common Stock
A - Award 64 15.057 0,43 104,56 6.729 1.574.390
2015-08-25 2015-08-23 4 AGN Allergan plc
Ordinary Shares, par value $0.0001
F - Taxes -124 2.602 -4,55 298,57 -37.023 776.879
2015-08-18 2015-08-15 4 AGN Allergan plc
Ordinary Shares, par value $0.0001
F - Taxes -100 2.726 -3,54 314,50 -31.450 857.327
2015-07-01 2015-06-30 4 DNB DUN & BRADSTREET CORP/NW
Phantom Stock Units - Deferred Compensation
A - Award 2.296 31.429 7,88 45,52 104.500 1.430.668
2015-06-30 2015-06-05 4/A AGN Allergan plc
Ordinary Shares, par value $0.0001
A - Award 826 2.826 41,30 302,30 249.700 854.300
2015-06-30 2015-06-04 4/A AGN Allergan plc
Ordinary Shares, par value $0.0001
F - Taxes -334 2.000 -14,31 303,38 -101.329 606.760
2015-06-16 2015-06-12 4 DNB DUN & BRADSTREET CORP/NW
Phanton Stock Units - Deferred
A - Award 102 29.134 0,35 48,14 4.931 1.402.498
2015-06-16 2015-06-12 4 DNB DUN & BRADSTREET CORP/NW
Common Stock
A - Award 52 14.993 0,35 129,73 6.705 1.945.033
2015-06-08 2015-06-05 4 ACT Actavis plc
Ordinary Shares, par value $0.0001
A - Award 826 2.826 41,30 302,30 249.700 854.300
2015-06-08 2015-06-04 4 ACT Actavis plc
Ordinary Shares, par value $0.0001
F - Taxes -334 2.000 -14,31 303,38 -101.329 606.760
2015-05-08 2015-05-06 4 ALXN ALEXION PHARMACEUTICALS INC
Option to Purchase Common Stock
A - Award 2.343 2.343 155,01 363.188 363.188
2015-05-08 2015-05-06 4 ALXN ALEXION PHARMACEUTICALS INC
Common Stock, par value $.0001 per share
A - Award 700 1.468 91,15
2015-05-08 2015-05-06 4 DNB DUN & BRADSTREET CORP/NW
Common Stock
A - Award 954 14.941 6,82
2015-03-13 2015-03-11 4 DNB DUN & BRADSTREET CORP/NW
Phantom Stock Units - Deferred
A - Award 104 29.031 0,36 47,20 4.911 1.370.277
2015-03-13 2015-03-11 4 DNB DUN & BRADSTREET CORP/NW
Common Stock
A - Award 49 13.987 0,35 127,20 6.241 1.779.249
2015-02-03 2015-01-30 4 DNB DUN & BRADSTREET CORP/NW
Phantom Stock Units - Deferred Compensation
A - Award 2.431 28.927 9,17 42,99 104.500 1.243.583
2015-01-28 2015-01-26 4 COV Covidien plc
Stock Option (Right to Buy)
D - Sale to Issuer -55.004 0 -100,00
2015-01-28 2015-01-26 4 COV Covidien plc
Stock Option (Right to Buy)
D - Sale to Issuer -55.004 0 -100,00
2015-01-28 2015-01-26 4 COV Covidien plc
Stock Option (Right to Buy)
D - Sale to Issuer -10.521 0 -100,00
2015-01-28 2015-01-26 4 COV Covidien plc
Stock Option (Right to Buy)
D - Sale to Issuer -14.109 0 -100,00
2015-01-28 2015-01-26 4 COV Covidien plc
Ordinary Shares
D - Sale to Issuer -7.970 0 -100,00
2015-01-28 2015-01-26 4 COV Covidien plc
Ordinary Shares
D - Sale to Issuer -49.475 0 -100,00
2014-12-16 2014-12-12 4 DNB DUN & BRADSTREET CORP/NW
Phantom Stock Units - Deferred Compensation
A - Award 100 26.496 0,38 42,50 4.271 1.126.100
2014-12-16 2014-12-12 4 DNB DUN & BRADSTREET CORP/NW
Common Stock
A - Award 51 13.938 0,37 114,86 5.914 1.600.871
2014-11-03 2014-10-30 4 ACT Actavis plc
Ordinary Shares, par value $0.0001
A - Award 694 18.261 3,95 243,21 168.788 4.441.258
2014-09-16 2014-09-12 4 DNB DUN & BRADSTREET CORP/NW
Phantom Stock Units - Deferred Compensation
A - Award 98 26.396 0,37 43,67 4.259 1.152.712
2014-09-16 2014-09-12 4 DNB DUN & BRADSTREET CORP/NW
Common Stock
A - Award 50 13.887 0,36 117,04 5.892 1.625.369
2014-07-24 2014-07-22 4 ALXN ALEXION PHARMACEUTICALS INC
Option to Purchase Common Stock
A - Award 2.706 2.706 167,97 454.527 454.527
2014-07-24 2014-07-22 4 ALXN ALEXION PHARMACEUTICALS INC
Common Stock, par value $.0001 per share
A - Award 768 768
2014-07-03 2014-07-01 4 FRX Forest Laboratories, LLC
Stock Option (Right to Buy)
D - Sale to Issuer -5.909 0 -100,00
2014-07-03 2014-07-01 4 FRX Forest Laboratories, LLC
Stock Option (Right to Buy)
D - Sale to Issuer -7.815 0 -100,00
2014-07-03 2014-07-01 4 FRX Forest Laboratories, LLC
Stock Option (Right to Buy)
D - Sale to Issuer -20.000 0 -100,00
2014-07-03 2014-07-01 4 FRX Forest Laboratories, LLC
Restricted Stock
D - Sale to Issuer -2.406 0 -100,00
2014-07-03 2014-07-01 4 FRX Forest Laboratories, LLC
Common Stock
D - Sale to Issuer -1.527 0 -100,00
2014-07-03 2014-07-01 4 ACT Actavis plc
Stock Option (Right to Buy)
A - Award 2.790 2.790
2014-07-03 2014-07-01 4 ACT Actavis plc
Stock Option (Right to Buy)
A - Award 3.691 3.691
2014-07-03 2014-07-01 4 ACT Actavis plc
Stock Option (Right to Buy)
A - Award 9.446 9.446
2014-07-03 2014-07-01 4 ACT Actavis plc
Ordinary Shares, par value $0.0001
A - Award 1.640 1.640
2014-07-02 2014-07-01 4 DNB DUN & BRADSTREET CORP/NW
Phantom Stock Units - Deferred Compensation
A - Award 2.501 26.298 10,51 41,79 104.500 1.099.012
2014-06-17 2014-06-13 4 DNB DUN & BRADSTREET CORP/NW
Phantom Stock Units - Deferred Compensation
A - Award 99 23.798 0,42 38,88 3.844 925.260
2014-06-17 2014-06-13 4 DNB DUN & BRADSTREET CORP/NW
Common Stock
A - Award 57 13.836 0,41 103,94 5.891 1.438.151
2014-05-23 2014-05-21 4 COV Covidien plc
Ordinary Shares
A - Award 420 49.446 0,86
2014-05-09 2014-05-07 4 DNB DUN & BRADSTREET CORP/NW
Common Stock
A - Award 1.141 13.780 9,03
2014-03-21 2014-03-19 4 COV Covidien plc
Ordinary Shares
F - Taxes -1.046 49.016 -2,09 70,68 -73.931 3.464.451
2014-03-21 2014-03-19 4 COV Covidien plc
Ordinary Shares
A - Award 2.264 50.062 4,74
2014-03-20 2014-03-18 4 DPRX Dipexium Pharmaceuticals, Inc.
Common Stock, par value $.001 per share
P - Purchase 2.083 109.309 1,94 12,00 24.996 1.311.708
2014-03-14 2014-03-12 4 DNB DUN & BRADSTREET CORP/NW
Phantom Stock Units - Deferred Compensation
A - Award 104 23.699 0,44 36,77 3.823 871.411
2014-03-14 2014-03-12 4 DNB DUN & BRADSTREET CORP/NW
Common Stock
A - Award 54 12.639 0,43 98,08 5.341 1.239.601
2014-03-12 3 DPRX Dipexium Pharmaceuticals, LLC
Common Stock, par value $.001 per share
214.452
2014-03-12 3 DPRX Dipexium Pharmaceuticals, LLC
Common Stock, par value $.001 per share
214.452
2014-02-24 2014-02-20 4 COV Covidien plc
Ordinary Shares
A - Award 12 47.798 0,03 71,28 855 3.407.041
2014-02-04 2014-01-31 4 DNB DUN & BRADSTREET CORP/NW
Phantom Stock Units - Deferred Compensation
A - Award 2.544 23.595 12,08 41,08 104.500 969.282
2013-12-17 2013-12-13 4 DNB DUN & BRADSTREET CORP/NW
Phantom Stock Units - Deferred Compensation
A - Award 72 21.051 0,34 42,99 3.087 904.990
2013-12-17 2013-12-13 4 DNB DUN & BRADSTREET CORP/NW
Common Stock
A - Award 42 12.584 0,33 116,06 4.839 1.460.524
2013-11-14 2013-11-12 4 DNB DUN & BRADSTREET CORP/NW
Non-Qualified Stock Option - right to buy
M - Exercise -2.746 0 -100,00
2013-11-14 2013-11-12 4 DNB DUN & BRADSTREET CORP/NW
Non-Qualified Stock Option - right to buy
M - Exercise -1.573 0 -100,00
2013-11-14 2013-11-12 4 DNB DUN & BRADSTREET CORP/NW
Common Stock
S - Sale -4.319 12.543 -25,61 110,75 -478.335 1.389.100
2013-11-14 2013-11-12 4 DNB DUN & BRADSTREET CORP/NW
Common Stock
M - Exercise 2.746 16.862 19,45 60,54 166.229 1.020.712
2013-11-14 2013-11-12 4 DNB DUN & BRADSTREET CORP/NW
Common Stock
M - Exercise 1.573 14.116 12,54 59,86 94.160 844.955
2013-11-07 2013-11-05 4 COV Covidien plc
Ordinary Shares
A - Award 13 47.786 0,03 64,33 836 3.074.073
2013-10-24 2013-10-22 4 DNB DUN & BRADSTREET CORP/NW
Phantom Stock Units - Deferred Compensation
A - Award 1.374 20.979 7,01 40,02 55.000 839.595
2013-09-20 2013-09-18 4 DNB DUN & BRADSTREET CORP/NW
Phantom Stock Units - Deferred Compensation
A - Award 72 19.605 0,37 40,32 2.884 790.476
2013-09-20 2013-09-18 4 DNB DUN & BRADSTREET CORP/NW
Common Stock
A - Award 45 12.543 0,36 106,96 4.821 1.341.548
2013-08-16 2013-08-15 4 FRX FOREST LABORATORIES INC
Stock Option (Right to Buy)
A - Award 5.909 5.909
2013-08-16 2013-08-15 4 FRX FOREST LABORATORIES INC
Common Stock
A - Award 1.761 3.933 81,08
2013-08-16 2013-08-15 4 COV Covidien plc
Ordinary Shares
A - Award 11 47.773 0,02 61,85 680 2.954.760
2013-07-19 2013-07-17 4 COV Covidien plc
Ordinary Shares
A - Award 248 47.762 0,52
2013-07-03 2013-07-01 4 DNB DUN & BRADSTREET CORP/NW
Phantom Stock Units - Deferred Compensation
A - Award 1.647 19.534 9,21 36,74 60.500 717.662
2013-06-17 2013-06-13 4 DNB DUN & BRADSTREET CORP/NW
Phantom Stock Units - Deferred Compensation
A - Award 70 17.887 0,40 37,25 2.626 666.285
2013-06-17 2013-06-13 4 DNB DUN & BRADSTREET CORP/NW
Common Stock
A - Award 49 12.497 0,39 98,79 4.802 1.234.623
2013-05-07 2013-05-03 4 COV Covidien plc
Ordinary Shares
A - Award 8 47.302 0,02 64,35 515 3.043.884
2013-03-22 2013-03-20 4 COV Covidien plc
Ordinary Shares
F - Taxes -1.052 47.294 -2,18 65,50 -68.906 3.097.757
2013-03-22 2013-03-20 4 COV Covidien plc
Ordinary Shares
A - Award 2.214 48.346 4,80
2013-03-18 2013-03-14 4 DNB DUN & BRADSTREET CORP/NW
Phantom Stock Units - Deferred Compensation
A - Award 86 17.816 0,48 30,51 2.622 543.577
2013-03-18 2013-03-14 4 DNB DUN & BRADSTREET CORP/NW
Common Stock
A - Award 59 12.449 0,47 81,23 4.778 1.011.219
2013-02-21 2013-02-19 4 DNB DUN & BRADSTREET CORP/NW
Common Stock
A - Award 1.453 12.390 13,29 82,56 119.952 1.022.858
2013-02-06 2013-02-05 4 COV Covidien plc
Stock Option (Right to Buy)
M - Exercise -12.000 0 -100,00
2013-02-06 2013-02-05 4 COV Covidien plc
Stock Option (Right to Buy)
M - Exercise -12.000 0 -100,00
2013-02-06 2013-02-05 4 COV Covidien plc
Stock Option (Right to Buy)
M - Exercise -12.000 0 -100,00
2013-02-06 2013-02-05 4 COV Covidien plc
Ordinary Shares
S - Sale -36.000 0 -100,00 62,05 -2.233.800
2013-02-06 2013-02-05 4 COV Covidien plc
Ordinary Shares
M - Exercise 12.000 36.000 50,00 36,99 443.884 1.331.651
2013-02-06 2013-02-05 4 COV Covidien plc
Ordinary Shares
M - Exercise 12.000 24.000 100,00 45,45 545.364 1.090.728
2013-02-06 2013-02-05 4 COV Covidien plc
Ordinary Shares
M - Exercise 12.000 12.000 45,66 547.890 547.890
2013-02-05 2013-02-01 4 DNB DUN & BRADSTREET CORP/NW
Phantom Stock Units - Deferred Compensation
A - Award 1.950 17.730 12,36 31,03 60.500 550.175
2012-12-28 2012-12-27 4 COV Covidien plc
Ordinary Shares
A - Award 12 46.132 0,03 57,35 688 2.645.670
2012-12-17 2012-12-13 4 DNB DUN & BRADSTREET CORP/NW
Phantom Stock Units - Deferred Compensation
A - Award 73 15.781 0,46 30,26 2.209 477.524
2012-12-17 2012-12-13 4 DNB DUN & BRADSTREET CORP/NW
Common Stock
A - Award 49 10.937 0,45 80,90 3.968 884.750
2012-11-07 2012-11-05 4 COV Covidien plc
Ordinary Shares
A - Award 13 46.120 0,03 55,65 723 2.566.578
2012-09-20 2012-09-18 4 DNB DUN & BRADSTREET CORP/NW
Phantom Stock Units - Deferred Compensation
A - Award 71 15.708 0,45 31,27 2.205 491.180
2012-09-20 2012-09-18 4 DNB DUN & BRADSTREET CORP/NW
Common Stock
A - Award 47 10.888 0,44 83,39 3.950 907.947
2012-08-27 2012-08-23 4 FRX FOREST LABORATORIES INC
Stock Option (Right to Buy)
A - Award 7.815 7.815
2012-08-27 2012-08-23 4 FRX FOREST LABORATORIES INC
Common Stock
A - Award 2.172 2.172
2012-08-20 2012-08-16 4 COV Covidien plc
Ordinary Shares
A - Award 10 46.107 0,02 57,59 576 2.655.302
2012-07-05 2012-07-02 4 DNB DUN & BRADSTREET CORP/NW
Phantom Stock Units - Deferred Compensation
A - Award 1.836 15.229 13,71 26,96 49.500 410.578
2012-06-15 2012-06-13 4 DNB DUN & BRADSTREET CORP/NW
Phantom Stock Units - Deferred Compensation
A - Award 73 13.393 0,55 25,56 1.879 342.328
2012-06-15 2012-06-13 4 DNB DUN & BRADSTREET CORP/NW
Common Stock
A - Award 58 10.841 0,54 67,32 3.928 729.734
2012-05-11 2012-05-09 4 DNB DUN & BRADSTREET CORP/NW
Phantom Stock Units - Deferred Compensation
A - Award 134 13.320 1,02 23,85 3.203 317.673
2012-05-09 2012-05-07 4 COV Covidien plc
Ordinary Shares
A - Award 11 46.097 0,02 54,25 597 2.500.762
2012-03-16 2012-03-14 4 DNB DUN & BRADSTREET CORP/NW
Phantom Stock Units - Deferred Compensation
A - Award 50 13.185 0,38 32,18 1.608 424.303
2012-03-16 2012-03-14 4 DNB DUN & BRADSTREET CORP/NW
Common Stock
A - Award 46 10.782 0,42 85,90 3.911 926.248
2012-03-14 2012-03-13 4 COV Covidien plc
Ordinary Shares
F - Taxes -1.033 46.086 -2,19 53,89 -55.668 2.483.575
2012-03-14 2012-03-13 4 COV Covidien plc
Ordinary Shares
A - Award 2.691 47.119 6,06
2012-03-05 2012-03-01 4 DNB DUN & BRADSTREET CORP/NW
Phantom Stock Units - Deferred Compensation
A - Award 1.590 13.135 13,77 31,14 49.500 409.034
2012-02-24 2012-02-22 4 COV Covidien plc
Ordinary Shares
A - Award 11 44.428 0,02 52,45 577 2.330.249
2012-02-15 2012-02-13 4 DNB DUN & BRADSTREET CORP/NW
Common Stock
A - Award 1.517 10.737 16,45 79,10 120.002 849.327
2008-10-09 2008-10-07 4 TYC TYCO INTERNATIONAL LTD /BER/
Stock Option (Right to Buy)
A - Award 184.700 184.700
2008-10-09 2008-10-07 4 TYC TYCO INTERNATIONAL LTD /BER/
Performance Share Units
A - Award 51.700 94.900 119,68
2005-08-08 2005-08-05 4 TYC TYCO INTERNATIONAL LTD /BER/
Common Shares
P - Purchase 10.000 110.000 10,00 27,24 272.400 2.996.400
2005-03-07 3 TYC TYCO INTERNATIONAL LTD /BER/
Common Shares
0
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)